Javier Beaumont

4.0k total citations · 1 hit paper
54 papers, 3.0k citations indexed

About

Javier Beaumont is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Javier Beaumont has authored 54 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 24 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Javier Beaumont's work include Cardiac Fibrosis and Remodeling (13 papers), Cardiovascular Function and Risk Factors (10 papers) and Nitric Oxide and Endothelin Effects (6 papers). Javier Beaumont is often cited by papers focused on Cardiac Fibrosis and Remodeling (13 papers), Cardiovascular Function and Risk Factors (10 papers) and Nitric Oxide and Endothelin Effects (6 papers). Javier Beaumont collaborates with scholars based in Spain, United Kingdom and United States. Javier Beaumont's co-authors include Javier Dı́ez, Gorka San José, Arantxa González, Begoña López, Susana Ravassa, Guillermo Zalba, María U. Moreno, Ana Fortuño, María Antonia Fortuño and Ramón Querejeta and has published in prestigious journals such as Journal of the American College of Cardiology, Circulation Research and Scientific Reports.

In The Last Decade

Javier Beaumont

53 papers receiving 3.0k citations

Hit Papers

Diffuse myocardial fibros... 2021 2026 2022 2024 2021 50 100 150 200

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Javier Beaumont 1.7k 909 544 460 323 54 3.0k
Julian D. Widder 1.5k 0.9× 768 0.8× 694 1.3× 685 1.5× 151 0.5× 49 2.9k
María U. Moreno 1.1k 0.7× 693 0.8× 671 1.2× 347 0.8× 249 0.8× 49 2.6k
Masao Takemoto 1.7k 1.0× 889 1.0× 825 1.5× 974 2.1× 344 1.1× 66 3.4k
Shunji Hayashidani 1.5k 0.9× 1.4k 1.6× 688 1.3× 449 1.0× 227 0.7× 22 3.3k
Gorka San José 1.3k 0.8× 758 0.8× 906 1.7× 407 0.9× 230 0.7× 51 3.1k
Pamela A. Lucchesi 1.4k 0.9× 1.9k 2.1× 614 1.1× 463 1.0× 206 0.6× 86 3.8k
Zhi‐Qing Zhao 1.2k 0.7× 1.1k 1.2× 391 0.7× 755 1.6× 209 0.6× 95 5.0k
Hope D. Intengan 1.3k 0.8× 472 0.5× 582 1.1× 343 0.7× 184 0.6× 22 2.4k
Petra Ročić 751 0.5× 1.2k 1.3× 780 1.4× 297 0.6× 263 0.8× 56 2.7k
Cesario Bianchi 952 0.6× 1.3k 1.5× 568 1.0× 844 1.8× 227 0.7× 106 3.5k

Countries citing papers authored by Javier Beaumont

Since Specialization
Citations

This map shows the geographic impact of Javier Beaumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Beaumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Beaumont more than expected).

Fields of papers citing papers by Javier Beaumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Beaumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Beaumont. The network helps show where Javier Beaumont may publish in the future.

Co-authorship network of co-authors of Javier Beaumont

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Beaumont. A scholar is included among the top collaborators of Javier Beaumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Beaumont. Javier Beaumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beaumont, Javier, Begoña López, Susana Ravassa, et al.. (2020). Author Correction: MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure. Scientific Reports. 10(1). 6703–6703.
2.
Ravassa, Susana, Javier Beaumont, Germán Cediel, et al.. (2020). Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?. Revista Española de Cardiología (English Edition). 73(10). 835–843. 5 indexed citations
3.
Ravassa, Susana, Begoña López, Ramón Querejeta, et al.. (2017). Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome. Journal of Hypertension. 35(4). 853–861. 57 indexed citations
4.
Beaumont, Javier, Begoña López, Susana Ravassa, et al.. (2017). MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure. Scientific Reports. 7(1). 40696–40696. 41 indexed citations
5.
López, Begoña, Susana Ravassa, Arantxa González, et al.. (2016). Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure. Journal of the American College of Cardiology. 67(3). 251–260. 110 indexed citations
6.
Moreno, María U., Rocío Eirós, Juán José Gavira, et al.. (2016). The Hypertensive Myocardium. Medical Clinics of North America. 101(1). 43–52. 27 indexed citations
7.
López, Begoña, Arantxa González, Susana Ravassa, et al.. (2015). Circulating Biomarkers of Myocardial Fibrosis. Journal of the American College of Cardiology. 65(22). 2449–2456. 196 indexed citations
8.
García, Raquel, J. Francisco Nistal, David Merino, et al.. (2015). p-SMAD2/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(7). 1520–1530. 34 indexed citations
9.
López, Begoña, Arantxa González, Diana Lindner, et al.. (2013). Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?. Cardiovascular Research. 99(1). 111–120. 109 indexed citations
10.
González, Arantxa, Begoña López, Susana Ravassa, et al.. (2012). Cardiotrophin-1 in hypertensive heart disease. Endocrine. 42(1). 9–17. 23 indexed citations
11.
González, Arantxa, Susana Ravassa, Javier Beaumont, Begoña López, & Javier Dı́ez. (2011). New Targets to Treat the Structural Remodeling of the Myocardium. Journal of the American College of Cardiology. 58(18). 1833–1843. 136 indexed citations
12.
López, Begoña, Arantxa González, Javier Beaumont, et al.. (2007). Identification of a Potential Cardiac Antifibrotic Mechanism of Torasemide in Patients With Chronic Heart Failure. Journal of the American College of Cardiology. 50(9). 859–867. 109 indexed citations
13.
González, Arantxa, Susana Ravassa, Begoña López, et al.. (2007). Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure. Journal of Hypertension. 25(10). 2148–2157. 45 indexed citations
14.
Ravassa, Susana, Arantxa González, Begoña López, et al.. (2007). Upregulation of myocardial Annexin A5 in hypertensive heart disease: association with systolic dysfunction. European Heart Journal. 28(22). 2785–2791. 29 indexed citations
15.
Beaumont, Javier, et al.. (2005). Modality-specific aspects of sustained and divided attentional performance in multiple sclerosis. Archives of Clinical Neuropsychology. 20(6). 705–718. 43 indexed citations
16.
Goikoetxea, M. J., Javier Beaumont, Arantxa González, et al.. (2005). Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease. Cardiovascular Research. 69(4). 899–907. 45 indexed citations
17.
Zalba, Guillermo, Javier Beaumont, Gorka San José, et al.. (2001). Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction?. Nephrology Dialysis Transplantation. 16(suppl_1). 2–5. 51 indexed citations
18.
Zalba, Guillermo, Javier Beaumont, Gorka San José, et al.. (2000). Vascular oxidant stress: Molecular mechanisms and pathophysiological implications. Journal of Physiology and Biochemistry. 56(1). 57–64. 98 indexed citations
19.
Varo, Nerea, J. C. Etayo, Guillermo Zalba, et al.. (1999). Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats. Journal of Hypertension. 17(1). 107–114. 111 indexed citations
20.
Wagner, Mark J., et al.. (1992). Intracellular regulation of cell adhesion to extracellular matrix components in murine B16 melanoma cells. Melanoma Research. 2(5). 345–354. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026